China-based private investigators receive prison terms

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

China-based private investigators receive prison terms

Peter Humphrey and Yu Yingzeng, the China-based investigators hired by GlaxoSmithKline to investigate corruption allegations, have been sentenced to 30 months and 24 months respectively for illegally obtaining private information

In a one-day trial, the Shanghai Intermediate Number One Court found that the British Humphrey (right) and Yu, his American wife, broke the law by illegally obtaining private information in the course of their investigations. In addition to the jail sentences, Humphrey received a RMB 200,000 fine ($32,500), while Yu was fined RMB 150,000. Humphrey will also be deported.

Humphrey and Yu have 10 days to appeal.

Donald Clarke of the Chinese Law Prof Blog has a copy of the Chinese language transcript posted by the court.

Humphrey and Yu are the founders of the private investigation firm ChinaWhys. In April 2013, GlaxoSmithKline hired the firm to investigate an anonymous email alleging that GSK employees were engaging in an elaborate bribery scheme. The detailed allegations also contained a video of GSK China head Mark Reilly in what appeared to be his Shanghai apartment.

In July 2013 Chinese authorities arrested Humphrey and Yu. Humphrey soon after issued an apology on Chinese television for his company's actions and said that he never intended to break Chinese law. GSK also admitted that its China-based executives had engaged in illegal activities.

The ChinaWhys case has been closely watched by international companies, as many regularly rely on private investigators to conduct due diligence on investments, business partners and other aspects of its business. This is especially true in IP enforcement, where companies often engage investigators to track down the sources of counterfeit goods.





more from across site and SHARED ros bottom lb

More from across our site

A decision on a licensing rate payable by Warner Bros and Paramount, and a survey outlining UK businesses’ lack of IP preparation ahead of launching abroad, were among other major talking points
A fresh wave of deals highlights why investors favour IP firms and why independent outfits may soon have to rethink their strategy
King & Spalding has now hired 15 partners from Winston Taylor and legacy firm Winston & Strawn in offices spanning Texas, San Francisco, and Chicago
Firm says its work with a biotech client could signal a sea change in how - and when - law firms enter the drug development process
Evan Lazerowitz, attorney in Robinson + Cole’s bankruptcy and reorganisation group, offers key takeaways for IP interested parties in bankruptcy and insolvency proceedings
While the UK sees heavy IP rankings movement, Germany’s new tiered UPC table signals a shift from early adoption to market maturity
In an exclusive interview, Bernard Ledeboer reveals how a Consolid-backed group of firms wants to expand across Europe, invest in AI and centralise operations to compete at the top tier
Not all private equity firms are the same, so leaders at four externally backed IP firms came together to discuss the frameworks they followed and how they ensured a cultural fit
Top-tier German and Spanish firms are among the advisers on a Europe-wide copyright and licensing tussle concerning the design of the track circuit in Madrid
Partners Alex Wilson and Andreas Kramer say bigger law firm rivals don’t necessarily gain by having a wider jurisdictional reach
Gift this article